- Home
- ATNF vs VRPX Comparison
ATNF vs VRPX Comparison
Compare ATNF & VRPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- VRPX
- Stock Information
- Founded
- ATNF 2016
- VRPX 2016
- Country
- ATNF United States
- VRPX United States
- Employees
- ATNF N/A
- VRPX N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- VRPX Medicinal Chemicals and Botanical Products
- Sector
- ATNF Health Care
- VRPX Health Care
- Exchange
- ATNF Nasdaq
- VRPX Nasdaq
- Market Cap
- ATNF 4.4M
- VRPX 2.2M
- IPO Year
- ATNF N/A
- VRPX 2021
- Fundamental
- Price
- ATNF $4.28
- VRPX $0.71
- Analyst Decision
- ATNF
- VRPX Hold
- Analyst Count
- ATNF 0
- VRPX 1
- Target Price
- ATNF N/A
- VRPX N/A
- AVG Volume (30 Days)
- ATNF 6.1M
- VRPX 392.4K
- Earning Date
- ATNF 11-07-2024
- VRPX 11-13-2024
- Dividend Yield
- ATNF N/A
- VRPX N/A
- EPS Growth
- ATNF N/A
- VRPX N/A
- EPS
- ATNF N/A
- VRPX N/A
- Revenue
- ATNF N/A
- VRPX N/A
- Revenue This Year
- ATNF N/A
- VRPX N/A
- Revenue Next Year
- ATNF $54.15
- VRPX N/A
- P/E Ratio
- ATNF N/A
- VRPX N/A
- Revenue Growth
- ATNF N/A
- VRPX N/A
- 52 Week Low
- ATNF $1.16
- VRPX $0.36
- 52 Week High
- ATNF $17.75
- VRPX $8.00
- Technical
- Relative Strength Index (RSI)
- ATNF 60.76
- VRPX 52.32
- Support Level
- ATNF $3.83
- VRPX $0.59
- Resistance Level
- ATNF $4.68
- VRPX $0.77
- Average True Range (ATR)
- ATNF 1.60
- VRPX 0.10
- MACD
- ATNF 0.07
- VRPX 0.02
- Stochastic Oscillator
- ATNF 19.00
- VRPX 74.51
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
About VRPX Virpax Pharmaceuticals Inc.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.